SDC1 and cancer: This study indicated that SDC1 expression exhibits varying impacts in pan-cancers, however, the higher SDC1 expression in breast tumor cells, but not in stromal cells, correlated with increased mortality, particularly in luminal molecular subtype, which might be a potential prognostic marker and therapeutic target for breast cancer therapy, especially in Luminal subtype breast cancer.